14-3-3 and β-catenin are secreted on extracellular vesicles to activate the oncogenic Wnt pathway

Shiri Dovrat, Michal Caspi, Alona Zilberberg, Lital Lahav, Anastasia Firsow, Hila Gur, Rina Rosin-Arbesfeld*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Abstract

Aberrant activation of the canonical Wnt signal transduction pathway is involved in a large number of human diseases. β-catenin, the key effector protein of the canonical Wnt pathway, functions in the nucleus with T-cell factor/lymphoid enhancer factor (TCF/LEF) to activate expression of Wnt target genes. Here we show that members of the 14-3-3 protein family bind disheveled-2 (Dvl-2) and glycogen synthase-3β (GSK-3β) to attenuate the interaction between GSK-3β and β-catenin. Importantly, 14-3-3 and β-catenin form "bleb-like" structures and are secreted via extracellular vesicles to induce Wnt signaling activity in target cells. Our data suggest a novel way of transducing the oncogenic Wnt signal in which β-catenin is regulated by 14-3-3ζ through the formation of "oncosomes" that contain both the 14-3-3 and β-catenin proteins.

Original languageEnglish
Pages (from-to)894-911
Number of pages18
JournalMolecular Oncology
Volume8
Issue number5
DOIs
StatePublished - Jul 2014

Funding

FundersFunder number
Alexander Smidoda
Ministry of Justice, Israel
Recanati Foundation
United States-Israel Binational Science Foundation
Israel Cancer Association
Israel Science Foundation20120016

    Keywords

    • 14-3-3
    • Exosomes
    • Extracellular vesicles
    • Wnt signaling
    • β-catenin

    Fingerprint

    Dive into the research topics of '14-3-3 and β-catenin are secreted on extracellular vesicles to activate the oncogenic Wnt pathway'. Together they form a unique fingerprint.

    Cite this